Employees’ protests against Trump science policies spread to NSF
Letter to key House Democrat follows declarations by scientists at NIH, EPA, and NASA
Related Articles
Columbia’s $221 million deal with Trump officials draws mixed reactions from researchers
Relief that NIH funding will be restored mingles with fears that academic independence will suffer—and that other universities will make similar concessions
Nearly Complete Human Genomes Reveal Complex Genetic Variation
A new study shows that over 99% of the human genome can be accurately assembled by focusing on 65 diverse humans.
Qualtrics Survey | Qualtrics Experience Management
The most powerful, simple and trusted way to gather experience data. Start your journey to experience management and try a free account today.
De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells
The recognition of intracellular antigens by CD8+ T cells through T cell receptors (TCRs) is central for adaptive immunity against infections and cancer. However, the…
Fifteen years later, Science retracts ‘arsenic life’ paper despite study authors’ protests
Belated decision on widely disputed 2010 study pleases some critics but puzzles and dismays others
LLMs in Medical School: A New Era of Learning
Some medical students are embracing LLMs for personalized learning and preparing for an AI-driven future in medicine.
Immunotherapy Response May Be Influenced by Patient’s Own Autoantibodies
Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.
Tissue origin and virus specificity shape human CD8+ T cell cytotoxicity
Memory CD8+ T cells have differential cytotoxic capacities across human tissues.
This scientist advises the U.K. government on climate policy—and it has to hear him out
As Piers Forster steps down as chair of the influential Climate Change Committee, he chats to Science about his role in guiding the country toward…
Beyond the native repertoire
Design of T cell receptors by artificial intelligence is poised to accelerate cancer immunotherapy
